Mechanism of PTEN deficient breast cancer detailed, suggesting improved therapeutics

A group of researchers led by the Dana-Farber Cancer Institute, Boston, has illustrated the mechanistic pathway for PTEN-deficient breast cancer and successfully tested a method of countering the downstream effects of immune system evasion by tumors.

source https://medicalxpress.com/news/2023-04-mechanism-pten-deficient-breast-cancer.html